Ashton Hébert’s Post

📈🤝𝐇𝐔𝐆𝐄 𝐀𝐜𝐪𝐮𝐢𝐬𝐢𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞 𝐂𝐌𝐎 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲🤝📈 CMO ROW here with some HUGE acquisition news coming from the Med Device CMO space this week, from both a key PE company and a large publicly traded player! 🌟 Nordson MEDICAL (a part of Nordson Corporation) have acquired Atrion Medical Products, Inc., Halkey-Roberts Corporation & Quest Medical, Inc. in a deal worth nearly $800M! This will allow them to add: Halkey Roberts’ infusion fluid delivery components, Atrion Medical’s OEM interventional inflation devices for balloon catheterization, stent deployment, and fluid delivery, and Quest Medical’s myocardial protection devices. Stephen Lovass (EVP Nordson Medical & Fluid Solutions) says, "Atrion’s highly talented organization, as well as its three FDA-registered design and manufacturing facilities, will be important additions to Nordson Medical. We look forward to being able to offer our medical customers a more comprehensive offering of solutions” 🌟 GTCR LLC acquire Surmodics, Inc. for $627M GTCR who already invest in Resonetics and Biocoat in the space, have further their coating interests through the acquisition of Surmodics! Surmodics (HQ'd in Eden Prairie, MN) cover both Medical Device Coatings (mainly vascular) along with IVD. Sean Cunningham (Managing Director & Head of Healthcare at GTCR) says, "With its longstanding, blue chip customer relationships and a rich history of developing medical technologies that deliver enhanced performance and improved clinical outcomes, Surmodics is well-positioned for attractive, long-term growth and value creation" 🤝 Best of luck to all involved for the year ahead and I hope all acquisitions run smoothly! ❓Did I miss anything? - let me know in the comments❓ If you're looking to hire CMO-experienced talent, please reach out as it would be good to learn more on your plans and where I could assist! 📞 +44 775-455-8706 / +1 929-294-7260 📩 [email protected] #medicaldevices #medicaldevicemanufacturing #cmo #contractmanufacturing #acquisition #growth

📉 Acutus Medical, Inc. to cut two-thirds of staff, shifting focus to Medtronic deal. 💼 The cardiac device maker reallocates capital from electrophysiology tools to left-heart access products. 💰 Restructuring aims to maximize potential earnings from the Medtronic deal and reduce cash burn. 👥 Approximately 65% of employees to be let go, impacting around 150 people. 🗓️ Restructuring expected to be completed in Q1 2024, transforming Acutus Medical, Inc. into a contract manufacturing business with all revenues from Medtronic. #medicaldevices #healthtech #medtech #business #restructuring #deal #cardiachealth #biotech #healthcareindustry #jobcuts #financialnews

Johnson & Johnson's robust first-quarter financial performance, particularly in their medical devices sector, showcases a promising rebound in demand for elective surgeries—a trend largely catalysed by the deferred medical needs during the pandemic. As the medtech division thrives, capitalising on the increasing surgical procedures among aging populations, it becomes clear that innovation and strategic acquisitions, like those of Shockwave Medical and Abiomed, are pivotal. This not only broadens J&J’s footprint in the cardiovascular technologies but also underscores the potential for growth in specialised medical equipment sectors. For companies like ours in the life science recruitment sector, J&J’s success story serves as a strong indicator of where the industry's job market might be headed. With J&J expanding its medtech division, there’s likely to be a surge in demand for skilled professionals in medical device engineering, surgical technology, and cardiovascular specialties. https://lnkd.in/dpSNZQUn #AspireLifeSciences #ai #drugdiscovery #healthcare #recruitment

Integer Holdings Corporation: A Leading Medical Device Manufacturer Navigating Growth and Innovation Integer Holdings Corporation is a global medical device outsourcing manufacturer that specializes in manufacturing medical devices for a wide range of original equipment manufacturers (OEMs) across the healthcare sector. The company has established a solid patient-focused foundation in cardiac rhythm, cardio and vascular health, neuromodulation devices, and custom medical battery packs and chargers for global OEMs. Integer reported a significant increase in its Q3 revenue, up 18% year-over-year, reaching $405 million, led by robust performances in its two largest segments — Cardio and vascular and Cardiac Rhythm Management and neuromodulation. The company's growth trajectory aligns with a strategy that combines in-house expansion and strategic acquisitions, potentially sustaining the company's momentum through 2024. Moreover, Integer's growth strategy extends beyond internal developments, with strategic acquisitions playing a pivotal role. The recent acquisition of neurovascular catheter maker InNeuro marked the third in a series of acquisitions over the past few years. These acquisitions have exceeded internal expectations and notably enhanced the company's profitability. #MedicalDevices #Manufacturing #Outsourcing #CardiacRhythmManagement #Neuromodulation #CardiovascularHealth #Innovation #Growth #Acquisitions

𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝘁𝗼 𝗥𝗲𝗮𝗰𝗵 $149.4 𝗕𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 2029𝗅 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲-https://lnkd.in/dJvgj2zb The size of global medical device contract manufacturing market in terms of revenue was estimated to be worth $78.9 billion in 2024 and is poised to reach $149.4 billion by 2029, growing at a CAGR of 11.4% from 2024 to 2029. 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻 𝗠𝗮𝗿𝗸𝗲𝘁 Medical Device Manufacturing St. Jude Medical Zimmer Biomet Arthrex Applied Medical Wright Medical Avanos Medical Inari Medical Confluent Medical Technologies Argon Medical Devices, Inc. Cirtec Medical Nalu Medical, Inc. Greatbatch Medical Paragon Medical Nissha Medical Technologies      Heraeus Medical Components   Vention Medical ForTec Medical, Inc. Lake Region Medical Harmac Medical Products Norwood Medical Medpace STERIS ClinChoice Orthofix Insulet Corporation MicroVention-Terumo Nevro Glidewell Dental Alphatec Spine Integer Holdings Corporation   Cutera, Inc. Verathon TekniPlex Sciton Biomerics AtriCure, Inc.  Acumed Resonetics Azzur Group

𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝘁𝗼 𝗥𝗲𝗮𝗰𝗵 $149.4 𝗕𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 2029𝗅 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲-https://lnkd.in/dJvgj2zb The size of global medical device contract manufacturing market in terms of revenue was estimated to be worth $78.9 billion in 2024 and is poised to reach $149.4 billion by 2029, growing at a CAGR of 11.4% from 2024 to 2029. 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻 𝗠𝗮𝗿𝗸𝗲𝘁 Medical Device Manufacturing St. Jude Medical Zimmer Biomet Arthrex Applied Medical Wright Medical Avanos Medical Inari Medical Confluent Medical Technologies Argon Medical Devices, Inc. Cirtec Medical Nalu Medical, Inc. Greatbatch Medical Paragon Medical Nissha Medical Technologies      Heraeus Medical Components   Vention Medical ForTec Medical, Inc. Lake Region Medical Harmac Medical Products Norwood Medical Medpace STERIS ClinChoice Orthofix Insulet Corporation MicroVention-Terumo Nevro Glidewell Dental Alphatec Spine Integer Holdings Corporation   Cutera, Inc. Verathon TekniPlex Sciton Biomerics AtriCure, Inc.  Acumed Resonetics Azzur Group

𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝘁𝗼 𝗥𝗲𝗮𝗰𝗵 $149.4 𝗕𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 2029𝗅 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲-https://lnkd.in/dJvgj2zb The size of global medical device contract manufacturing market in terms of revenue was estimated to be worth $78.9 billion in 2024 and is poised to reach $149.4 billion by 2029, growing at a CAGR of 11.4% from 2024 to 2029. 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻 𝗠𝗮𝗿𝗸𝗲𝘁 Medical Device Manufacturing St. Jude Medical Zimmer Biomet Arthrex Applied Medical Wright Medical Avanos Medical Inari Medical Confluent Medical Technologies Argon Medical Devices, Inc. Cirtec Medical Nalu Medical, Inc. Greatbatch Medical Paragon Medical Nissha Medical Technologies      Heraeus Medical Components   Vention Medical ForTec Medical, Inc. Lake Region Medical Harmac Medical Products Norwood Medical Medpace STERIS ClinChoice Orthofix Insulet Corporation MicroVention-Terumo Nevro Glidewell Dental Alphatec Spine Integer Holdings Corporation   Cutera, Inc. Verathon TekniPlex Sciton Biomerics AtriCure, Inc.  Acumed Resonetics Azzur Group

Happy Monday! Bringing you a Q2 2023 Snapshot of 3 MedTech Giants 💡 Stryker, Johnson & Johnson, and Zimmer Biomet posted their second-quarter financial results for 2023 and data on their orthopedic sales, but what do these numbers mean for them? https://lnkd.in/gwQkR2nZ Stryker's chair and CEO, Kevin A. Lobo, says they delivered strong organic sales growth as the demand for their products remains strong. They're back on their margin expansion pathway, and their super cycle of innovation is going well. https://lnkd.in/gDsBWT6h Zimmer Biomet's Chairman, President, and CEO, Bryan Hanson, says their performance and execution for Q2 allowed them to deliver another strong quarter above their expectations, giving them the freedom to raise their financial guidance for the rest of 2023 based on their recent performance, the strength of their innovation pipeline and the Zimmer Biomet team's ability to deliver for our key stakeholders. https://lnkd.in/gTWB7phM Johnson & Johnson's Chairman of the Board and Chief Executive Officer, Joaquin Duato, says their robust performance in the second quarter is a testament to their coworkers' hard work and commitment. They're entering the last half of the year from a position of strength, with motivations including becoming a two-sector company focused on Pharmaceutical and MedTech innovation. https://lnkd.in/gR4spQvZ Endless innovations from these companies mean better healthcare for everyone and different job opportunities in the industry. 💊 #MedTechNews #MedicalDevices #HealthcareInnovation #MedTechIndustry #HealthTech #HealthcareTechnology #MedDeviceNews #HealthcareNews #MedTechTrends